Funding: New Awards

Barbara Conradt, PhD
Associate Professor
Cancer Mechanisms

    3 R01 GM069950-07S1
    Analysis of Cell Death Regulation in C. elegans

Patricia A. Ernst, PhD
Assistant Professor
Cancer Mechanisms

  • Lauri Strauss Leukemia Foundation (LSLF)
    2010 Discovery Research Grant

Brian W. Pogue, PhD
Associate Professor
Cancer Imaging and Radiobiology

  • US Army Medical Research Acquisition Act
    Epithelial and Stromal Spectral Imaging for rapid surgical Margin Analysis

James R. Rigas, MD
Associate Professor
Molecular Therapy

  • Pfizer
    Phase 2, Open-Label Single arm Study of the Efficacy and Safety of PF-02341066 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring a Translocation or Inversion Involving the Anaplastic Lymphoma Kinase (ALK) Gene Locus
  • Pfizer
    Phase III, Randomized, Open-label study of the chemotherapy (pemetrexed or docetaxel) in Patients with Advanced non-small cell lung cancer (NSCLC) Harboring a translocation or Inversion even involving the Anaplastic Lymphoma Kinase (ALK Gene Locus)

Charles L. Sentman, PhD
Associate Professor
Immunology and Cancer Immunotherapy

  • NIH/sub with CELDARA Medical, LLC
    1 R43 HL0099217-01A1
    ChNKG2D-Targeted Cellular Cancer Therapy: Preclinical Toxicology

Mark R. Spaller, PhD
Assistant Professor
Cancer Control

  • NCI/sub with Mayo Clinic Rochester
    1 R01 CA150190-01
    Targeting Pancreatic Cancer using Peptide chemistry; From Bench to Bedside